Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Neos Therapeutics (NEOS)

8.7 -0.1 (-1.14%)

02-22 16:00

Open:

8.9

Pre. Close:

8.8

High:

9.05

Low:

8.65

Volume:

324,538

Market Cap:

252M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

9.064 - 9.127

9.127 - 9.176

Low:

8.488 - 8.572

8.572 - 8.636

Close:

8.584 - 8.698

8.698 - 8.785

Technical analysis  (as of: 2018-02-22 5:02:03 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 12.30     One year: 13.65

Support:

Support1: 8.65    Support2: 7.20

Resistance:

Resistance1: 10.53    Resistance2: 11.69

Pivot:

9.36

Moving Averages:

MA(5): 9.01     MA(20): 9.79

MA(100): 9.80     MA(250): 8.38

MACD:

MACD(12,26): -0.41     Signal(12,26,9): -0.30

%K %D:

%K(14,3): 4.31     %D(3): 9.46

RSI:

RSI(14): 30.02

52-Week:

High: 13.15  Low: 5.7  Change(%): 46.2

Average Vol(K):

3-Month: 37326  10-Days 29943

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
NEOS has closed above bottom band by 3.6%. Bollinger Bands are 35.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 20 Feb 2018 14:48:45 GMT
Neos Therapeutics Reiterates Confidence in Strategic Plan and Value Creation ...

Fri, 23 Feb 2018 03:11:15 GMT
Neos Therapeutics, Inc. (NEOS) Analysts See $-0.61 EPS

Tue, 20 Feb 2018 12:22:30 GMT
PDL BioPharma Says No Longer Pursue Proposed Acquisition Of Neos Therapeutics

Wed, 21 Feb 2018 15:33:45 GMT
Cheap or Expensive Right Now? – Neos Therapeutics, Inc. (NEOS), AVEO ...

Thu, 01 Feb 2018 22:30:30 GMT
Neos Therapeutics Inc. (NEOS) Moves Lower on Volume Spike for February 01

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

29.00

Shares Float (M)

27.20

% Held by Insiders

% Held by Institutions

52.70

Shares Short (K)

2622

Shares Short Prior Month (K)

2560

Stock Financials

EPS

-3.420

EPS Est. Current Year

-3.110

EPS Est. Next Year

-1.440

EPS Est. Next Quarter

-0.670

Forward EPS

-1.539

Book Value (p.s.)

18.250

PEG Ratio

-0.05

Profit Margin

Operating Margin

-299.77

Return on Assets (ttm)

-65.5

Return on Equity (ttm)

-449.8

Qtrly Rev. Growth

322.9

Gross Profit (p.s.)

0.245

Sales Per Share

EBITDA (p.s.)

-2.002

Qtrly Earnings Growth

Operating Cash Flow (M)

-58.21

Levered Free Cash Flow (M)

-37.86

atoplab.com

Valuation

P/E

-2.54

P/E Growth Ratio

-0.01

P/BV

0.48

P/S

262812496.00

P/CF

-4.33

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.